Text or WhatsApp Richard at (808) 600-9260
Lion crestHealthcareInvestmentBanking.com

Quality of Earnings (QoE) Prep Checklist for Healthcare Sellers

QoE prep means proving every dollar of adjusted EBITDA before the buyer's accountants test it. Five workstreams carry most of the value: add-backs with an invoice behind each line, provider pay reset to market, collections tied to bank deposits, accrual revenue by payer and a working capital peg built from monthly history. Start about 90 days before you approach buyers. The 28 items below follow the order a buyer's QoE team works. The scoring rule at the end tells you whether you are ready for fieldwork.

Data as of November 2026. Each figure names its source, period and population where it appears. All worked examples are hypothetical. The arithmetic is ours, and each example states its assumptions.

Sell-side QoE, buyer QoE and audit: what each one does

Sell-side QoE Buyer-side QoE Financial statement audit
Who orders it Seller, before marketing Buyer, after the LOI Owner or lender, annually
What it tests Adjusted EBITDA, revenue quality, NWC, debt-like items The same, plus anything the buyer plans to change after close Whether statements follow accounting standards
Add-backs Built and supported by the seller Accepted, reduced or reversed Not addressed
Who it protects Seller's price and peg Buyer's price and escrow Users of the statements
When findings cost the least Before any buyer sees the numbers Never cheap for the seller Not a deal document

A sell-side QoE does not replace the buyer's. It sets the starting point, so the buyer's team spends its time confirming your numbers instead of building its own.

Who will run the buyer-side QoE

In private equity, most healthcare deals are add-ons. The Private Equity Stakeholder Project's 2025 review, built on PitchBook and LevinPro HC data, tracked 1,029 PE-backed healthcare deals in calendar 2025: 664 add-on acquisitions, 151 leveraged buyouts and 214 growth investments, involving 420 platform companies and 708 investment firms. Add-ons were 64.5% of the total (our arithmetic, 664 of 1,029). PESP says its count is likely an underestimate.

Subsector, calendar 2025 (PESP, PitchBook and LevinPro HC data) PE deals What it means for your QoE
Health IT 151 Revenue recognition, contract terms and recurring revenue get the most scrutiny
Dental care 149 95% were add-ons by PE-owned platforms. Expect the platform's standard diligence template
Outpatient care 148 119 were add-ons. Dermatology (24) and eye care (22) led by deal count, followed by oncology (9), per Becker's ASC Review reporting PESP data
Medtech 117 Product margin, inventory and customer concentration lead the work
Behavioral health 56 Payer audits, licensing and staffing costs are tested hard

PESP also reports that 10 of the 18 platform companies with the most deals in 2025 were dental companies. A repeat acquirer runs the same QoE playbook on every add-on. It knows which add-backs it will reject before your file arrives.

Buyers are also paying less per dollar of EBITDA, which leaves less room for weak add-backs. PitchBook's median healthcare M&A multiple, as reported in Sikich's Q3 2026 market update, was 14.5x EV/EBITDA in 2024, 13x in 2025 and 11.6x for 2026 year to date through that Q3 update.

This checklist is built for practices, facilities and services businesses. Hospital deals run at a different scale. Kaufman Hall's Q3 2026 report (Oct 13, 2026) counted 16 hospital and health system transactions in the quarter, with average seller size approaching $586 million in annual revenue.

What a $450,000 QoE reversal costs at closing

Every reversed add-back comes off the price at the multiple. That is the base case. A smaller EBITDA can also give the buyer an argument for a lower multiple. Sikich's Q3 2026 update gives indicative physician practice ranges of 7 to 9x EBITDA at $1 million to $3 million of EBITDA and 9 to 11x at $3 million to $5 million. Those bands describe the market across many practices. They do not mean a single practice reprices when it crosses a line, so treat the lower-multiple columns below as a downside scenario, not a forecast.

Worked example (hypothetical, our arithmetic). A specialty group presents $3.2 million of adjusted EBITDA and expects 10x, the midpoint of the Sikich $3 million to $5 million band. The buyer's QoE reverses $450,000 of owner compensation and rent add-backs, leaving $2.75 million.

Seller's number Base case: same multiple Downside: 9.0x Downside: 8.0x Downside: 7.0x
Adjusted EBITDA $3,200,000 $2,750,000 $2,750,000 $2,750,000 $2,750,000
Multiple (assumed) 10.0x 10.0x 9.0x 8.0x 7.0x
Enterprise value $32,000,000 $27,500,000 $24,750,000 $22,000,000 $19,250,000
Value lost vs seller's number $4,500,000 $7,250,000 $10,000,000 $12,750,000

The base case loses $4.5 million on a $450,000 reversal. If the buyer also wins the argument for a lower band, the loss runs from $7.25 million to $12.75 million. At $2.75 million of EBITDA, each turn of multiple is worth $2.75 million. A practice whose other numbers test clean has the strongest case for holding its multiple.

That is why the sell-side work belongs before the LOI. Once a buyer holds exclusivity, every gap its QoE finds turns into a price cut, an escrow or an earnout. The LOI and term sheet red flags checklist shows how those cuts get written in.

Table 1: Add-backs and one-time items (items 1 to 8)

# Item Why buyers care Document or proof Red flag
1 Add-back schedule tied to the general ledger Each add-back adds to the price at the multiple Monthly schedule showing GL account, amount, invoice and a one-line rationale Round-number add-backs with no invoice behind them
2 Owner personal expenses (auto, travel, family on payroll) Valid only if the cost goes away after close Card statements, payroll register showing roles and hours A family member is added back but actually works the front desk
3 Non-recurring legal, settlement and consulting fees Buyers accept them only if they truly don't recur Engagement letters, settlement agreements, closing invoices "One-time" legal costs that show up in three straight years
4 Government relief, grant and other non-operating income Buyers strip it from run-rate revenue Award letters, GL coding that separates it from patient revenue The income is still sitting inside net patient revenue
5 Start-up losses at new locations Pro forma credit for sites that are still ramping Site-level P&L, opening date, monthly visit ramp Full run-rate claimed for a site open less than 12 months
6 Recruiting, severance and relocation costs These recur at any practice that is growing Offer letters, separation agreements, recruiter invoices Recruiting added back while provider turnover stays high
7 Rent reset for owner-held real estate The post-close lease sets the true occupancy cost Current lease, proposed post-close lease, market rent support Below-market rent to the owner's entity that the buyer resets upward
8 Pro forma payer rate increases and new contracts Future revenue only counts if it is signed Executed contract, fee schedule, effective date Credit taken for a contract still in negotiation

Items 1 and 7 do the most damage when they fail. A rent reset lowers EBITDA, so a seller who owns the building should model the post-close lease before the buyer does.

Worked example (hypothetical, our arithmetic). A practice with about $1.5 million of EBITDA pays its owner's real estate entity $180,000 a year. Market rent for the space is $260,000. The buyer's QoE charges the $80,000 gap against EBITDA. At an assumed 8x, the midpoint of the Sikich $1 million to $3 million band, that is $640,000 of enterprise value. If the seller sets the post-close lease at market first, the rent question gets negotiated in the real estate sale, where it belongs.

Will the add-back survive? A decision table

Add-back type Survives when Fails when Typical buyer treatment if it fails
Owner perks and family payroll The cost ends at close and payroll shows no real role The person does work that someone must be paid to do Reversed, plus a market-wage hire charged in
One-time legal or consulting A single event with closing invoices Similar costs recur across years Reversed in full
New-site ramp Twelve or more months of site data show a stable trend Credit is claimed on a forecast Reversed or moved to an earnout
Rent normalization The post-close lease is signed at the normalized rate The figure is not backed by a lease Reset to market rent
Pro forma payer rates The contract is executed with an effective date The contract is still in negotiation Excluded from run-rate
Owner comp normalization Production data, market benchmark and signed employment terms all agree The normalized salary is below replacement cost Reset to replacement cost, gap often escrowed

Table 2: Provider compensation and missing costs (items 9 to 14)

# Item Why buyers care Document or proof Red flag
9 Owner-physician comp reset to market Post-close salary defines the EBITDA the buyer is paying for Production (wRVUs or collections), market benchmark, proposed employment terms Owner pay normalized below what a replacement would cost
10 Associate provider comp against production Shows whether margin survives a change in owner Provider contracts, monthly production and compensation reports Bonuses paid off-cycle and never accrued
11 Staffing at market wages Open roles covered by the owner or by overtime hide real cost Org chart, open positions, local wage data such as the BLS Health Care and Social Assistance data An unfilled practice manager role with the work absorbed by the owner
12 Full cost base present (malpractice, benefits, IT, billing) A missing line means EBITDA is overstated Policies, renewal quotes, vendor invoices Malpractice paid personally by the owner and absent from the P&L
13 Related-party arrangements (billing company, MSO, leasing) Buyers test whether pricing reflects fair market value and whether the arrangement continues after close Written agreements, FMV support, 24 months of payments A spouse-owned billing vendor with no written contract
14 Medical director stipends and payments to referral sources Compliance exposure as well as cost Signed agreements, time logs, FMV support Payments to referring physicians with no FMV support

Item 12 is the cheapest fix on this page. Put every missing cost on the P&L at market rate before a buyer finds it. Item 9 has to match two documents: the QoE schedule and the post-close employment agreement. When the two salaries differ, buyers usually underwrite the higher one, and the seller ends up negotiating from the weaker number.

Some QoE lines rest on legal conclusions, and a change after legal review flows straight into EBITDA or the closing funds flow.

Have your attorney review these areas before the pro forma is final. The site's High-risk area pages, the healthcare compliance due diligence guide and the management services organizations guide show where each one comes up in the deal timeline.

Table 3: Revenue cycle, payer mix and cash vs accrual (items 15 to 23)

# Item Why buyers care Document or proof Red flag
15 Monthly net revenue by payer, 36 months Covers two fiscal years plus the trailing twelve months and shows trend, seasonality and concentration Practice management system reports reconciled to the GL Payer reports that don't tie to the financial statements
16 Payer mix and concentration Each payer class carries its own rate, policy and audit risk Revenue and visits by payer class, top 5 payers as share of revenue One payer above a third of revenue with a contract up for renewal
17 Proof of cash Confirms that reported collections reached the bank Bank deposits reconciled to PM system collections by month An unexplained gap between deposits and posted payments
18 AR aging by payer, with net realizable value AR feeds working capital and, through revenue, EBITDA Aging buckets by payer, historical collection rates by bucket Balances over 120 days carried at full value
19 Cash to accrual conversion Buyers underwrite EBITDA by date of service Revenue by date of service, net of expected contractual adjustments A strong cash year that was really a collections catch-up
20 Contractual adjustments and denial trends Rising denials point to falling future revenue Denial reports by reason code, write-off history Write-offs booked in lumps at year end
21 Credit balances and payer overpayments Buyers treat unrefunded overpayments as liabilities and often escrow for them Credit balance report by payer, refund log, dates each overpayment was identified Credit balances aging with no refund process
22 Coding and billing sample Upcoding exposure becomes a price cut or an indemnity Internal or external coding audit, E/M level distribution E/M distribution well above specialty norms with no audit on file
23 Payer contract terms Rates and assignment rights decide whether revenue transfers Executed contracts, fee schedules, termination and change-of-control clauses Contracts that can be terminated on a change of control

Payer mix matters because each payer class moves on its own policy cycle. The CMS National Health Expenditure fact sheet shows the national split for 2024: Medicare spending grew 7.8% to $1,118.0 billion (21% of total), private health insurance spending was $1,644.6 billion (31%) and out-of-pocket spending was $556.6 billion (11%). Physician and clinical services spending grew 8.1% to $1,109.7 billion in 2024. A buyer compares your mix to its own book and models rate risk payer by payer, which is why item 16 has to tie to item 15 by month.

Items 17 through 21 carry the most weight in a government-heavy book. Clean collections, a documented denial history and a working refund process are how a Medicare or Medicaid book earns full credit. Sikich's Q3 2026 update reports that home health and hospice multiples moved down in 2026 and that buyers discount billing and compliance risk. It cites the Enhabit take-private at 10.2x and puts small agencies at mid-single digits. Part of that gap is scale. The part a seller controls is the revenue cycle evidence.

Worked example (hypothetical, our arithmetic). A seller carries $400,000 of AR over 120 days at full value. History shows that bucket collects 20 cents on the dollar, so net realizable value is $80,000 and the overstatement is $320,000. What it costs depends on how the peg and the closing balance sheet are measured. Assumption: a similar old balance sat in the AR every month of the peg history.

Scenario Peg built on Closing AR measured at NWC effect at close
Consistent NRV in every historical month NRV About zero. The write-down lowers the peg and the delivered NWC by roughly the same $320,000
Mismatched Full-value history NRV $320,000 shortfall, paid dollar for dollar

The write-down can also reach EBITDA. If those balances came from revenue booked above what payers actually pay, the QoE lowers revenue in the months it was booked, and any part that falls in the trailing twelve months comes off EBITDA at the multiple. Writing the balance down before fieldwork, and building every month of NWC history on the same basis, keeps the issue to an accounting entry instead of a price fight. Buyers will still test aging and collection rates. They test them faster against a schedule that is consistent.

Table 4: Net working capital and the balance sheet (items 24 to 28)

# Item Why buyers care Document or proof Red flag
24 NWC definition and monthly history The peg sets the dollar-for-dollar price adjustment at close 12 to 24 months of month-end NWC on the agreed definition The seller lets the buyer define NWC first
25 Accrued compensation, PTO and bonus true-ups Unaccrued obligations become a price reduction PTO balances, bonus plans, provider true-up formulas Annual bonuses expensed only when paid
26 Deferred revenue and patient prepayments Cash already collected for services the buyer will deliver Prepaid package ledger, membership and treatment plan balances Cosmetic or dental plan prepayments booked as revenue
27 Debt-like items Deducted from enterprise value to reach equity value Equipment leases, deferred rent, payer recoupments, unrefunded overpayments, unpaid taxes Recoupment letters left out of the data room
28 Tax filings and entity status Tax exposure follows the seller through the reps Three years of federal, state, payroll and sales tax returns, plus entity elections Late payroll deposits or a missing S-corporation election

Worked example (hypothetical, our arithmetic). The buyer proposes an NWC peg of $1.2 million, built from monthly history in which it added bonus accruals and deferred patient prepayments using its own estimates. Closing NWC on the purchase agreement's definition comes in at $1.05 million. The price drops $150,000, dollar for dollar. The seller had no monthly history on the same definition, so it had no evidence to argue the peg should have been lower. Building item 24 with accruals in place lets the seller negotiate the peg from its own numbers.

From headline price to cash at close

Sellers anchor on enterprise value. The wire at closing is smaller. This walk uses the 8.0x downside scenario from the $450,000 example above.

Worked example (hypothetical, our arithmetic). Assumptions: enterprise value of $22 million (8x on $2.75 million), no funded bank debt, and $600,000 of equipment leases, $180,000 of open payer recoupments and $120,000 of unrefunded credit balances, all treated as debt-like under the assumed purchase agreement definitions. Each agreement sets its own list. The walk also includes the $150,000 NWC shortfall from the prior example and an escrow of $1.1 million (5% of enterprise value, an illustrative assumption for a deal without representations and warranties insurance). Transaction fees and taxes are left out.

Step Amount Running total
Enterprise value $22,000,000
Less equipment leases ($600,000) $21,400,000
Less open payer recoupments ($180,000) $21,220,000
Less unrefunded credit balances ($120,000) $21,100,000
Less NWC shortfall vs peg ($150,000) $20,950,000
Less escrow held back ($1,100,000) $19,850,000 cash at close

The gap between headline price and closing cash is $2.15 million. Of that, $1.05 million is permanent: $900,000 of debt-like items under items 21 and 27 plus the $150,000 shortfall under items 24 and 25. The $1.1 million escrow is deferred, not lost, and comes back to the seller to the extent no claims are made against it. A seller who documents and settles the debt-like items before the QoE controls how they are counted. A clean refund and recoupment history is the best argument for a smaller escrow.

Items 22, 27 and 28 still matter after closing. SRS Acquiom's 2026 Deal Terms for M&A Escrows found that seller general reps survived closing in 43% of the 2025 deals in its dataset where representations and warranties insurance was identified. Insurance does not always take the seller out of the risk. Where a rep survives, an error in the records the QoE tested can come back as a claim. A problem found, fixed and listed on the disclosure schedules before signing is priced once.

6 adjustments buyers reverse most often

  1. Owner compensation set below replacement cost (item 9).
  2. Rent normalized down to a figure the post-close lease won't honor (item 7).
  3. "One-time" costs that appear in two or more years (items 3 and 6).
  4. Pro forma revenue from unsigned contracts or sites still ramping (items 5 and 8).
  5. Cash-basis revenue presented as run-rate during a collections catch-up (item 19).
  6. Missing cost lines that the buyer charges back in at market rate (item 12).

Each reversal also makes the buyer trust the rest of the schedule less. When that happens, buyers move value out of cash at close and into escrows, holdbacks and earnouts. The deal structures guide explains how those terms are built.

Size changes what the QoE measures

See the healthcare multiples by segment and size chart.

Small practices sell on seller's discretionary earnings (SDE), which include the owner's pay. Larger practices sell on EBITDA after a market salary is deducted. Once a practice is priced on EBITDA, item 9 becomes the largest single line in its QoE. The table below draws on three private-deal datasets with different populations, so compare rows within one source only.

Source and population Size or segment Median or range
Axia Growth, closed healthcare small-business sales, aggregated and de-identified, updated Oct 28, 2026 Under $500K SDE 3.4x SDE (182 deals)
Axia Growth, same dataset $2M to $3M EBITDA 5.1x EBITDA (13 deals)
Axia Growth, same dataset $10M+ EBITDA 12.9x EBITDA (17 deals)
Sikich Q3 2026 update, indicative ranges Physician practices, $1M to $3M EBITDA 7 to 9x
Sikich, same update Physician practices, above $5M EBITDA 11 to 13x
Sikich, same update Dental platforms vs add-ons 9 to 11x vs 5 to 8x
Sikich, same update Single-specialty ASCs vs regional ASC operators 5 to 8x vs 11 to 17x
PitchBook data reported by Sikich, calendar 2025 Median PE-backed healthcare services company, implied EBITDA of roughly $33M 13.6x
BuckheadFMV, 187 U.S. healthcare services control deals with disclosed prices, Jan 2023 to Oct 2026 All deals with positive EBITDA 9.6x EBITDA (68 deals), 10.1x excluding distressed sales
BuckheadFMV, same dataset Deals under $10M 2.8x EBITDA (median)
BuckheadFMV, same dataset Deals above $200M 11.2x EBITDA (median)
BuckheadFMV, same dataset Ambulatory surgery centers 12.4x EBITDA (median)

How the datasets differ. Axia Growth's figures come from closed small-business sales, so they reflect owner-operated practices and small samples in the upper bands. Sikich's ranges are indicative bands that skew toward sponsor-backed deals. BuckheadFMV uses only transactions with a disclosed or court-approved price from SEC filings, state transaction filings, bankruptcy court approvals and Medicare cost reports. It notes that large and public deals disclose EBITDA more often than small private ones, so its EBITDA medians lean toward larger transactions. That helps explain why its ASC median sits nearer the Sikich regional-operator range than the single-specialty range.

Public companies are a separate population again. Aswath Damodaran's NYU Stern dataset puts US Healthcare Support Services at 11.17x EV/EBITDA and Hospitals/Healthcare Facilities at 8.86x as of January 2026. Those are liquid, scaled businesses. Read them as a ceiling reference, not a price for a private practice.

Each step up in size raises the value of every add-back that survives. Within the Axia dataset, in the two bands priced on EBITDA, a $100,000 add-back is worth $510,000 at the 5.1x median for $2 million to $3 million of EBITDA and $1.29 million at the 12.9x median above $10 million (our arithmetic, from small samples of 13 and 17 deals). Specialty benchmarks are in the healthcare valuation multiples guide.

Multi-site sellers should build items 15 through 20 for each site as well as for the group. The healthcare data room checklist gives a folder structure for this.

Match every QoE number to the document that governs it after close

Buyers test each normalized figure against the contract that will set it after closing. When the two disagree, buyers generally underwrite whichever number costs more. Before fieldwork starts, put each line below next to its governing document and confirm the figures match.

QoE line Item Governing post-close document Check before fieldwork
Owner-physician salary 9 Post-close employment agreement Same base pay, productivity formula and benefit load in both
Associate provider comp 10, 25 Provider contracts as assigned or reissued Bonus and true-up formulas accrued at the contract rates
Occupancy cost 7 Post-close lease Rent, escalator and term match the add-back schedule
Related-party fees (billing, MSO, leasing) 13 Written services agreement The fee in the pro forma equals the fee in the agreement
Medical director stipends 14 Signed directorship agreement and time logs Stipend matches the agreement and the logs support the hours
Pro forma payer revenue 8, 23 Executed payer contracts and fee schedules Effective dates confirmed and change-of-control terms reviewed
NWC peg 24 Purchase agreement NWC definition The same accounts, on the same basis, appear in the monthly history and the definition
Debt-like items 21, 27 Closing funds flow Each item has an amount, support and a payoff source
Escrow sizing 21, 22, 27 Escrow agreement Recoupment and refund history supports the amount requested

The rent example above shows what a mismatch costs: an $80,000 gap between the QoE and the lease is $640,000 of enterprise value at 8x.

QoE kickoff packet: what the provider needs on day one

Fieldwork moves at the pace of the first document request. A provider that gets a complete packet on day one spends its hours testing your numbers instead of chasing files. Put these folders together before fieldwork starts, and check each one against its "ready when" test.

Folder Contents Items covered Ready when
Monthly financials 36 months of closed monthly P&L, balance sheet and GL detail 1, 15, 24 Every month is closed and ties to the annual statements
Bank and cash Statements for every bank account and the monthly proof of cash 17 Deposits reconcile to PM system collections each month
Revenue by payer PM system reports by payer, site and date of service 15, 16, 19, 20 Monthly totals tie to the GL
AR and credits AR aging by payer, collection history by bucket, credit balance report, refund log 18, 21 Old balances are carried at net realizable value in every month
Add-back support Add-back schedule, invoices, settlement letters, site P&Ls 1 to 8 Every line passes the decision table above
Provider comp Contracts, production reports, market benchmark, draft post-close employment terms 9, 10, 25 The QoE salary matches the draft agreement
Related parties Written agreements, FMV support, 24 months of payments 7, 13, 14 Every arrangement is in writing and has been through legal review
Payer contracts Executed contracts and fee schedules 8, 23 Effective dates and change-of-control terms are flagged
Debt-like items and tax Leases, recoupment letters, three years of returns, open tax notices 27, 28 Each item has an amount and support

Choosing the sell-side QoE provider

Buyers give less weight to a QoE from the firm that prepares your returns or audits your books, because that firm would be testing its own work. Engage an independent provider and screen candidates on the criteria below.

Criterion What to ask for What it protects
Healthcare deal experience Recent sell-side and buy-side QoE engagements in your specialty and payer mix Specialty norms for comp, coding and denials drive the adjustments
Revenue cycle testing Proof of cash, payer-level AR rollforward, NRV by aging bucket, credit balance review Items 17 to 21 are where healthcare QoEs fail
Provider comp normalization Method for benchmarking wRVUs and collections against market data Item 9 is the largest single adjustment for most practices
NWC peg analysis Monthly NWC on a proposed definition, with seasonality Sets your opening position on the peg
Debt-like item schedule A list of leases, recoupments, overpayments and tax items with support Controls the walk from enterprise value to cash at close
Site-level work Separate testing for each location Buyers test sites one by one
Timing Fieldwork finished before marketing starts Findings need time to be fixed, not just disclosed
Buyer access Willingness to walk buyer diligence teams through the work Shortens the back-and-forth on contested items

If a sell-side banker will run the process, check the firm and the individual bankers on FINRA BrokerCheck before you sign an engagement letter.

Scoring rule: count the items you can prove today

Give yourself one point for each of the 28 items where the document exists today and ties to the general ledger. A plan to fix something scores zero.

Score Status Next step
24 to 28 QoE-ready Start sell-side fieldwork now
18 to 23 Close Engage the provider now and fix gaps in parallel over 60 days
Under 18 Not ready Run the full 90-day plan before talking to buyers

A red flag on item 9, 17 or 19 puts you in the bottom band, whatever your total. Those three items decide whether the buyer believes your EBITDA at all.

30/60/90-day order of work

Days 1 to 30: books, evidence and provider selection - Select and engage the sell-side QoE provider using the criteria above. Agree on scope and the fieldwork date. - Close the books monthly and reconcile every bank account for 36 months. - Build the proof of cash (item 17) and monthly revenue by payer (item 15). - Draft the add-back schedule with an invoice behind every line (items 1 to 8), and run each line through the decision table. - Put malpractice, benefits and every other missing cost on the P&L (item 12).

Days 31 to 60: normalization - Convert to accrual by date of service (item 19). - Benchmark owner and associate compensation against production and FMV survey data (items 9 and 10). - Put all related-party and referral-source arrangements in writing with FMV support, and send them through the legal review described above (items 13 and 14). - Build monthly NWC and AR aging by payer, with net realizable value applied in every month of the history (items 18 and 24). - Refund identified overpayments and document the credit balance process (item 21). - Finish the kickoff packet and confirm the target closing timeline.

Days 61 to 90: fieldwork and packaging - Give the provider the add-back schedule first and start fieldwork. - Drop or document every add-back the provider challenges. Don't argue the weak ones with buyers. - Run a coding sample and review change-of-control terms in payer contracts (items 22 and 23). - Build the debt-like item schedule and the walk from enterprise value to cash at close (item 27). - Load the final QoE and support into the data room before any LOI, then move to the sell-side readiness checklist. The healthcare M&A process guide shows where the QoE sits in the full sale timeline.

Use the practice valuation calculator to see what each surviving add-back is worth at your multiple.

Questions owners ask

What is a sell-side quality of earnings report?

It is an independent accounting review that the seller orders before going to market. It tests reported and adjusted EBITDA, revenue quality and net working capital. Buyers still run their own QoE. The sell-side version lets you find and fix gaps first, back every add-back with documents and set a working capital peg from evidence instead of accepting the buyer's first draft.

How do buyers normalize owner-physician compensation?

They replace what the owner actually took with what it will cost to pay that physician, or a replacement, after closing. The proof is production data such as wRVUs or collections, a market compensation benchmark and the proposed post-close employment terms. Setting owner pay below market inflates EBITDA on paper. Buyers reverse it in diligence or move the difference into escrow and earnout terms.

Do I need accrual-basis financials if my practice files taxes on a cash basis?

You don't need them for tax. Most buyers want them for the sale, because they underwrite EBITDA by date of service. On that basis, revenue is recorded when the service is performed, net of expected contractual adjustments, and expenses are matched to the same period. Converting your books before the QoE shows whether a strong cash year came from real growth or from a collections catch-up that will not repeat.

How many months of data should a sell-side QoE cover?

Most buyers ask for at least two full fiscal years plus the trailing twelve months, by month. The exact window varies with the buyer and the deal size. Building 36 months of monthly data covers that window for any likely closing date and shows three seasonal cycles. Multi-site sellers need the same depth for every location, because buyers test each site separately and one weak site can reprice the whole group.

Should I fix a problem the QoE finds or just disclose it?

Do both. Fix what can be fixed before marketing, such as missing accruals, unrefunded credit balances or undocumented related-party arrangements. Then put the issue and the fix on the disclosure schedules. A problem the buyer discovers on its own costs more than the dollar amount, because it lowers the buyer's trust in every other number in the file.

Does a clean QoE affect indemnity terms after closing?

It changes how much the seller has at risk. SRS Acquiom's 2026 Deal Terms for M&A Escrows found that seller general reps survived closing in 43% of the 2025 deals in its dataset where representations and warranties insurance was identified. Reps on financial statements, tax and billing rest on the same records the QoE tests. A problem found, fixed and scheduled before signing is priced once. One found after closing becomes a claim.

Sources